neostigmine has been researched along with Respiration Disorders in 10 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Respiration Disorders: Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The authors hypothesized that the choice of neuromuscular blockade reversal (neostigmine vs." | 7.96 | Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis. ( Bardia, A; Bartels, K; Bash, LD; Colquhoun, DA; Dubovoy, TZ; Kheterpal, S; Mathis, MR; McCormick, PJ; Saager, L; Schonberger, RB; Shah, NJ; Shanks, AM; Soto, RG; Vaughn, MT, 2020) |
| "Prospective observational series of consecutive patients scheduled for laparoscopic bariatric surgery in whom neuromuscular blockade was reverted with sugammadex were compared with a historical matched cohort of patients reverted with neostigmines." | 7.80 | Postoperative respiratory outcomes in laparoscopic bariatric surgery: comparison of a prospective group of patients whose neuromuscular blockade was reverted with sugammadex and a historical one reverted with neostigmine. ( Cabrera, A; Camprubí, I; Ferreres, E; Llauradó, S; Sabaté, A, 2014) |
| " The authors hypothesized that the choice of neuromuscular blockade reversal (neostigmine vs." | 3.96 | Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis. ( Bardia, A; Bartels, K; Bash, LD; Colquhoun, DA; Dubovoy, TZ; Kheterpal, S; Mathis, MR; McCormick, PJ; Saager, L; Schonberger, RB; Shah, NJ; Shanks, AM; Soto, RG; Vaughn, MT, 2020) |
| "Prospective observational series of consecutive patients scheduled for laparoscopic bariatric surgery in whom neuromuscular blockade was reverted with sugammadex were compared with a historical matched cohort of patients reverted with neostigmines." | 3.80 | Postoperative respiratory outcomes in laparoscopic bariatric surgery: comparison of a prospective group of patients whose neuromuscular blockade was reverted with sugammadex and a historical one reverted with neostigmine. ( Cabrera, A; Camprubí, I; Ferreres, E; Llauradó, S; Sabaté, A, 2014) |
| "Neostigmine was associated with a dose-dependent increase in the risk of postoperative respiratory complications (OR, 1." | 1.42 | Dose-dependent Association between Intermediate-acting Neuromuscular-blocking Agents and Postoperative Respiratory Complications. ( Diaz-Gil, D; Eikermann, M; Farhan, HN; Kurth, T; Ladha, KS; McLean, DJ, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suleiman, A | 1 |
| Munoz-Acuna, R | 1 |
| Azimaraghi, O | 1 |
| Houle, TT | 1 |
| Chen, G | 1 |
| Rupp, S | 1 |
| Witt, AS | 1 |
| Azizi, BA | 1 |
| Ahrens, E | 1 |
| Shay, D | 1 |
| Wongtangman, K | 1 |
| Wachtendorf, LJ | 1 |
| Tartler, TM | 1 |
| Eikermann, M | 2 |
| Schaefer, MS | 1 |
| Ji, Y | 1 |
| Yuan, H | 1 |
| Chen, Y | 1 |
| Zhang, X | 1 |
| Wu, F | 1 |
| Tang, W | 1 |
| Lu, Z | 1 |
| Huang, C | 1 |
| Kheterpal, S | 1 |
| Vaughn, MT | 1 |
| Dubovoy, TZ | 1 |
| Shah, NJ | 1 |
| Bash, LD | 1 |
| Colquhoun, DA | 1 |
| Shanks, AM | 1 |
| Mathis, MR | 1 |
| Soto, RG | 1 |
| Bardia, A | 1 |
| Bartels, K | 1 |
| McCormick, PJ | 1 |
| Schonberger, RB | 1 |
| Saager, L | 1 |
| Piskin, O | 1 |
| Altinsoy, B | 1 |
| Cimencan, M | 1 |
| Aydin, BG | 1 |
| Okyay, D | 1 |
| Kucukosman, G | 1 |
| Tascilar, O | 1 |
| Sarikaya, S | 1 |
| Ayoglu, H | 1 |
| Llauradó, S | 1 |
| Sabaté, A | 1 |
| Ferreres, E | 1 |
| Camprubí, I | 1 |
| Cabrera, A | 1 |
| McLean, DJ | 1 |
| Diaz-Gil, D | 1 |
| Farhan, HN | 1 |
| Ladha, KS | 1 |
| Kurth, T | 1 |
| Martinez-Ubieto, J | 1 |
| Ortega-Lucea, S | 1 |
| Pascual-Bellosta, A | 1 |
| Arazo-Iglesias, I | 1 |
| Gil-Bona, J | 1 |
| Jimenez-Bernardó, T | 1 |
| Muñoz-Rodriguez, L | 1 |
| Cammu, GV | 1 |
| Smet, V | 1 |
| De Jongh, K | 1 |
| Vandeput, D | 1 |
| Gawley, TH | 1 |
| Dundee, JW | 1 |
| Lobzin, VS | 1 |
| Saĭkova, LA | 1 |
| Poliakova, LA | 1 |
| Vasil'ev, VN | 1 |
| Zhulev, NM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Validation of the REPS Prediction Tool to Improve Quality of Perioperative Care[NCT03585400] | 101,510 participants (Actual) | Observational | 2018-06-29 | Completed | |||
| Importance of Understanding Provider Variability in the Use of Neuromuscular Blocking Drugs and Reversal Agents[NCT03585348] | 265,537 participants (Actual) | Observational | 2018-06-29 | Completed | |||
| Accessor Blinded Randomized Controlled Study Evaluating the Efficacy and Safety of Sugammadex in High-Risk Ambulatory Surgeries[NCT03944473] | Phase 4 | 0 participants (Actual) | Interventional | 2019-06-20 | Withdrawn (stopped due to Stopped before IRB approval) | ||
| Neuromuscular Monitoring, Reversal of Block and Postoperative Residual Curarization: the Situation in 2018[NCT03665805] | 587 participants (Actual) | Observational | 2018-07-30 | Completed | |||
| Visualization of Regional Lung Ventilation During Neostigmine or Sugammadex Enhanced Recovery From Moderate Residual Neuromuscular Blockade in the Anaesthetized Rat Using Functional Respiratory Imaging[NCT02284412] | Phase 4 | 13 participants (Actual) | Interventional | 2014-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for neostigmine and Respiration Disorders
| Article | Year |
|---|---|
Sugammadex Is Associated With Reduced Pulmonary Complications in Patients With Respiratory Dysfunction.
Topics: Cholinesterase Inhibitors; Humans; Neostigmine; Neuromuscular Blockade; Pleural Effusion; Postoperat | 2023 |
1 trial available for neostigmine and Respiration Disorders
| Article | Year |
|---|---|
Attempts to reduce respiratory complications following upper abdominal operations.
Topics: Abdomen; Adolescent; Adult; Anesthesia; Carbon Dioxide; Hot Temperature; Humans; Humidity; Middle Ag | 1981 |
8 other studies available for neostigmine and Respiration Disorders
| Article | Year |
|---|---|
The effects of sugammadex vs. neostigmine on postoperative respiratory complications and advanced healthcare utilisation: a multicentre retrospective cohort study.
Topics: Adult; Cholinesterase Inhibitors; Humans; Neostigmine; Neuromuscular Blockade; Patient Acceptance of | 2023 |
Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis.
Topics: Cholinesterase Inhibitors; Cohort Studies; Female; Humans; Male; Middle Aged; Neostigmine; Neuromusc | 2020 |
The effect of bariatric anaesthesia on postoperative pulmonary functions.
Topics: Adult; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; Bariatric Surgery; Bl | 2017 |
Postoperative respiratory outcomes in laparoscopic bariatric surgery: comparison of a prospective group of patients whose neuromuscular blockade was reverted with sugammadex and a historical one reverted with neostigmine.
Topics: Adult; Aged; Bariatric Surgery; Cholinesterase Inhibitors; Female; gamma-Cyclodextrins; Humans; Lapa | 2014 |
Dose-dependent Association between Intermediate-acting Neuromuscular-blocking Agents and Postoperative Respiratory Complications.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Dose-Response | 2015 |
Dose-dependent Association between Intermediate-acting Neuromuscular-blocking Agents and Postoperative Respiratory Complications.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Dose-Response | 2015 |
Dose-dependent Association between Intermediate-acting Neuromuscular-blocking Agents and Postoperative Respiratory Complications.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Dose-Response | 2015 |
Dose-dependent Association between Intermediate-acting Neuromuscular-blocking Agents and Postoperative Respiratory Complications.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Dose-Response | 2015 |
Prospective study of residual neuromuscular block and postoperative respiratory complications in patients reversed with neostigmine versus sugammadex.
Topics: Anesthesia Recovery Period; Atracurium; Cholinesterase Inhibitors; Delayed Emergence from Anesthesia | 2016 |
A prospective, observational study comparing postoperative residual curarisation and early adverse respiratory events in patients reversed with neostigmine or sugammadex or after apparent spontaneous recovery.
Topics: Adult; Aged; Anesthesia Recovery Period; Body Mass Index; Female; gamma-Cyclodextrins; Humans; Male; | 2012 |
A prospective, observational study comparing postoperative residual curarisation and early adverse respiratory events in patients reversed with neostigmine or sugammadex or after apparent spontaneous recovery.
Topics: Adult; Aged; Anesthesia Recovery Period; Body Mass Index; Female; gamma-Cyclodextrins; Humans; Male; | 2012 |
A prospective, observational study comparing postoperative residual curarisation and early adverse respiratory events in patients reversed with neostigmine or sugammadex or after apparent spontaneous recovery.
Topics: Adult; Aged; Anesthesia Recovery Period; Body Mass Index; Female; gamma-Cyclodextrins; Humans; Male; | 2012 |
A prospective, observational study comparing postoperative residual curarisation and early adverse respiratory events in patients reversed with neostigmine or sugammadex or after apparent spontaneous recovery.
Topics: Adult; Aged; Anesthesia Recovery Period; Body Mass Index; Female; gamma-Cyclodextrins; Humans; Male; | 2012 |
[Criteria for severity and prognosis of the course of myasthenia].
Topics: Adolescent; Adult; Aged; Cholinesterase Inhibitors; Electromyography; Female; Humans; Male; Middle A | 1985 |